Description
YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor with an IC50 of 2.12 nM/1.40 nM/2.86 nM, respectively. YKL-06-062 is the structural analog of YKL-06-062.
Product information
CAS Number: 2172617-16-0
Molecular Weight: 525.69
Formula: C31H39N7O
Chemical Name: 1-cyclohexyl-3-(2,6-dimethylphenyl)-7-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-1H,2H,3H,4H-pyrimido[4,5-d][1,3]diazin-2-one
Smiles: CN1CCN(CC1)C1C=CC(=CC=1)NC1N=C2C(CN(C(=O)N2C2CCCCC2)C2C(C)=CC=CC=2C)=CN=1
InChiKey: GFXPGVPPWWPDPV-UHFFFAOYSA-N
InChi: InChI=1S/C31H39N7O/c1-22-8-7-9-23(2)28(22)37-21-24-20-32-30(34-29(24)38(31(37)39)27-10-5-4-6-11-27)33-25-12-14-26(15-13-25)36-18-16-35(3)17-19-36/h7-9,12-15,20,27H,4-6,10-11,16-19,21H2,1-3H3,(H,32,33,34)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: DMSO : 25 mg/mL (47.56 mM; Need ultrasonic).
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
YKL 06-062 (0.0004-16 μM; 3 hours) increases MITF mRNA expression in a dose-dependent manner.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.